特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
955998

小腸がん - 世界の臨床試験レビュー

Small Intestine Cancer Global Clinical Trials Review, H1, 2020

出版日: | 発行: GlobalData | ページ情報: 英文 | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.70円
小腸がん - 世界の臨床試験レビュー
出版日: 2020年06月15日
発行: GlobalData
ページ情報: 英文
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の小腸がんの臨床試験について調査分析し、臨床試験シナリオの概要、治験数、平均登録数のほか、世界の治験情勢、主要データ、主要企業などについて、体系的な情報を提供しています。

目次

  • ガイダンス
  • 調査範囲
  • 臨床試験:地域別
  • 治験数と平均登録数:国別
  • アジア太平洋地域における臨床試験に貢献している上位5ヶ国
  • 欧州における臨床試験に貢献している上位5ヶ国
  • 北米における臨床試験に貢献している上位国
  • 中東・アフリカにおける臨床試験に貢献している上位国
  • 中南米における臨床試験に貢献している上位国
  • 臨床試験:G7諸国別 - 腫瘍の臨床試験に対する小腸がんの割合
  • 臨床試験:G7諸国のフェーズ別
  • G7諸国の臨床試験:治験ステータス別
  • 臨床試験:E7諸国別 - 腫瘍の臨床試験に対する小腸がんの割合
  • 臨床試験:E7諸国のフェーズ別
  • E7諸国の臨床試験:治験ステータス別
  • 臨床試験:フェーズ別
  • 進行中の治験:フェーズ別
  • 臨床試験:治験ステータス別
  • 臨床試験:評価項目ステータス別
  • 一定期間募集された被験者数
  • 臨床試験:スポンサータイプ別
  • 有力なスポンサー
  • 小腸がん治療の臨床試験に参加している主要企業
  • 有力な医薬品
  • 臨床試験プロファイルのスナップショット

付録

図表

List of Tables

List of Tables

  • Small Intestine Cancer Therapeutics, Global, Clinical Trials by Region, 2020*
  • Small Intestine Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Small Intestine Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Small Intestine Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020*
  • Small Intestine Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
  • Small Intestine Cancer Therapeutics Clinical Trials, North America, Top Countries, 2020*
  • Small Intestine Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2020*
  • Small Intestine Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2020*
  • Proportion of Small Intestine Cancer to Oncology Clinical Trials, G7 Countries (%), 2020*
  • Small Intestine Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Small Intestine Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Small Intestine Cancer to Oncology Clinical Trials, E7 Countries (%), 2020*
  • Small Intestine Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Small Intestine Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Small Intestine Cancer Therapeutics, Global, Clinical Trials by Phase, 2020*
  • Small Intestine Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
  • Small Intestine Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Small Intestine Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Small Intestine Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Small Intestine Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
  • Small Intestine Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Small Intestine Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Small Intestine Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*

List of Figures

List of Figures

  • Small Intestine Cancer Therapeutics, Global, Clinical Trials by Region (%), 2020*
  • Small Intestine Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Small Intestine Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Small Intestine Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020*
  • Small Intestine Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020*
  • Small Intestine Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2020*
  • Small Intestine Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2020*
  • Small Intestine Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2020*
  • Proportion of Small Intestine Cancer to Oncology Clinical Trials, G7 Countries (%), 2020*
  • Small Intestine Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Small Intestine Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Small Intestine Cancer to Oncology Clinical Trials, E7 Countries (%), 2020*
  • Small Intestine Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Small Intestine Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Small Intestine Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2020*
  • Small Intestine Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2020*
  • Small Intestine Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Small Intestine Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Small Intestine Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Small Intestine Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020*
  • Small Intestine Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Small Intestine Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Small Intestine Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
  • GlobalData Methodology
目次
Product Code: GDHC6292CTIDB

GlobalData's clinical trial report, "Small Intestine Cancer Global Clinical Trials Review, H1, 2020" provides an overview of Small Intestine Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Small Intestine Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

List of Tables

List of Figures

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Small Intestine Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Small Intestine Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Small Intestine Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Disclaimer
  • Source
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.